Drug
Azelastine clinical trials
- studies test it
- 31
- open now
- 2
- in phase 3
- 15
- first study started
- 2005
Keep track of what changes. Save the azelastine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
31 studies that test it; most in 2007 (5)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 3
- Phase 3
- 15
- Phase 4
- 7
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 24 · Other 7
Meda Pharmaceuticals (11) · MEDA Pharma GmbH & Co. KG (4) · University of Chicago (3) · Sandoz (2) · Humanis Saglık Anonim Sirketi (1) · Bayer (1) · AstraZeneca (1) · Hanlim Pharm. Co., Ltd. (1)
Often tested with
Tested in the same studies.
Fluticasone (11) · Mometasone Furoate (5) · Ciclesonide (1) · Budesonide (1) · Gsk-256066 (1) · Montelukast (1)
Studies
Open first, then newest update. How each study uses azelastine is read from its arms, and is right about nine times in ten.
Testing it · 31
- A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 InfectionRecruitingPhase 4University of ChicagoNCT06008860Written as Experimental: Primary Cohort
- Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic RhinitisRecruitingPhase 4Endeavor HealthNCT05626621Written as Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray
- Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic RhinitisCompletedPhase 4University of ChicagoNCT02402465Written as Fluticasone/Azelastine nasal spray
- Azelastine Allergen Chamber - Onset of Action StudyCompletedPhase 2MEDA Pharma GmbH & Co. KGNCT06126952Written as Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
- Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal SprayCompletedPhase 1Humanis Saglık Anonim SirketiNCT06180083Written as Azelastine Hydrochloride/ Fluticasone propionate nasal spray
- Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic RhinitisTerminatedPhase 1SandozNCT05887843Written as Mometasone + Azelastine
- Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic RhinitisCompletedPhase 3SandozNCT05311475Written as Azelastine
- Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic RhinitisCompletedPhase 3BayerNCT04264637Written as Azelastine hydrochloride (BAYR9258)
- MP-AzeFlu Allergen Chamber - Onset of Action StudyCompletedPhase 4MEDA Pharma GmbH & Co. KGNCT03004131Written as Azelastine hydrochloride + fluticasone propionate nasal spray
- Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal SpraysCompletedPhase 1MEDA Pharma GmbH & Co. KGNCT01194622Written as Azelastine, Fluticasone
- Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal SpraysCompletedPhase 1MEDA Pharma GmbH & Co. KGNCT01190852Written as Azelastine, Fluticasone
- Comparison of Montelukast and Azelastine in Treatment of Moderate to Severe Allergic RhinitisStatus unknownNot applicableShiraz University of Medical SciencesNCT04561687Written as Azelastine
- Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)CompletedPhase 4AstraZenecaNCT00806754Written as Ciclesonide nasal spray + Azelastine
- AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)Status unknownPhase 4Universitaire Ziekenhuizen KU LeuvenNCT02238353Written as azelastine + fluticasone
- Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)CompletedPhase 3Meda PharmaceuticalsNCT01915823Written as azelastine hydrochloride and fluticasone propionate
- A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic RhinitisCompletedPhase 3Meda PharmaceuticalsNCT00720382Written as 0.15% azelastine hydrochloride
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedPhase 3Meda PharmaceuticalsNCT00660829Written as 0.15% Azelastine Hydrochloride
- Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™Status unknownPhase 3Teva Pharmaceuticals USANCT02249663Written as Azelastine hydrochloride and Fluticasone propionate
- Nasal Ocular Reflexes Contribute to Eye SymptomsCompletedNot applicableUniversity of ChicagoNCT00117832Written as Azelastine nasal spray
- Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic RhinitisCompletedPhase 3Hanlim Pharm. Co., Ltd.NCT01470053Written as mometasone furoate plus azelastine HCl
See all 31 studies that test azelastine →
Given in every arm · 1 — azelastine is usual care beside what is tested
As the comparator · 9 — what is tested is compared with azelastine
- Thermosensitive Gel Nasal Spray With Exosomes, Azelastine, and Interferon for Acute Phase of Chronic SinusitisNot yet recruitingEarly Phase 1The First Affiliated Hospital of Xinxiang Medical CollegeNCT07635459Written as Azelastine and Interferon alpha-2b
- Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film DysfunctionCompletedPhase 4Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaNCT06800274Written as azelastine hydrochloride 0.05%
- Allergic Rhinitis Combination Pharmacotherapy Efficacy StudyWithdrawnPhase 4St. Paul's Sinus CentreNCT04601324Written as Azelastine hydrochloride and fluticasone propionate
- Efficacy and Safety Study of AI201901 in Allergic Rhinitis PatientsCompletedPhase 3Abdi Ibrahim Ilac San. ve Tic A.S.NCT04729517Written as Azelastine Hydrochloride
- DYmista NAsal Spray in CHInese PatientsCompletedPhase 3MEDA Pharma GmbH & Co. KGNCT03599791Written as Azelastine Hydrochloride 0.137 MG/ACTUAT
- Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic RhinitisCompletedPhase 2Merck Sharp & Dohme LLCNCT01382654Written as azelastine 0.1%
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedPhase 3Meda PharmaceuticalsNCT00651118Written as azelastine Hcl
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedPhase 3Meda PharmaceuticalsNCT00660517Written as azelastine Hcl
- Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor RhinitisCompletedPhase 4Alcon ResearchNCT00979615Written as Azelastine HCl (Astelin) Nasal Spray, 137 mcg
Codes
What other systems call azelastine · ClinicalTrials.gg INT002735
- MeSH (NLM) C020976azelastineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) ZQI909440XAZELASTINEConfirmed FDA, NLM, Wikidata
- RxNorm 18603Confirmed FDA, Wikidata
- Wikidata Q419820azelastineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61643AzelastineOne source FDA
- DrugBank DB00972One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C020976 | azelastine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | ZQI909440X | AZELASTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 18603 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419820 | azelastine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61643 | Azelastine | One source FDA |
| DrugBank | DB00972 | — | One source Wikidata |
Also registered as azelastine hydrochloride (UNII 0L591QR10I · RxNorm 235824).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.